Superworth

Ironwood Pharmaceuticals market cap IRWD

Share price times shares outstanding: what the whole company sells for, since 2011.

Today, Nov 2, 2026
$571.7M
Highest close in our data
$3.2B
Jul 2018

Ironwood Pharmaceuticals is worth $571.7M at the close on Nov 2, 2026, at $3.46 a share.

That is up 83% over the last year and down 73% over five years.

Its highest close in our data was $3.2B in Jul 2018.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$571.7M$495.7M$850.8M+10%
2025$520.6M$91.6M$721.7M−27%
2024$712.1M$548.9M$2.4B−60%
2023$1.8B$1.3B$1.9B−6%
2022$1.9B$1.5B$2B−0%
2021$1.9B$1.5B$2.3B+5%
2020$1.8B$1.5B$2.1B−14%
2019$2.1B$1.4B$2.3B+38%
2018$1.5B$1.4B$3.2B−32%
2017$2.2B$2B$2.9B+0%
2016$2.2B$1.2B$2.4B+35%
2015$1.7B$1.5B$2.3B−21%
2014$2.1B$1.2B$2.2B+45%
2013$1.4B$1.1B$2B+22%
2012$1.2B$1.1B$1.6B−2%
2011$1.2B$1.1B$1.4Bn/a

Against its peers

Companies in Drug Manufacturers - General nearest Ironwood Pharmaceuticals' size, closest first, today.

CompanyMarket cap
IRWDIronwood Pharmaceuticals$571.7M
ZVRAZevra Therapeutics$599.8M
PBYIPuma Biotechnology$525.5M
ARVNArvinas$491.7M
COLLCollegium Pharmaceutical$770.9M
CRMDCorMedix$420.1M
ABUSArbutus Biopharma$791.4M
AMPHAmphastar Pharmaceuticals$1.1B
OMEROmeros$1.3B
ANABAnaptysbio$1.4B
PCRXPacira BioSciences$1.5B
Peer median$781.2M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Ironwood Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.